We (Déchanet-Merville group) identified EPCR as a target for non-Vδ2 γδ T cells that is expressed on endothelial cells infected by cytomegalovirus (CMV) and is also similarly expressed on epithelial tumor cells (28). The gene discussed is PROCR; the disease is neoplasm.